UB Paderborn / Katalog / Suche / in CDI

Am Donnerstag, den 15.8. kann es zwischen 16 und 18 Uhr aufgrund von Wartungsarbeiten des ZIM zu Einschränkungen bei der Katalognutzung kommen.

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

1 – 25 von 2.673

Sortiert nach

Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumours

British journal of cancer, 2012-01, Vol.106 (3), p.468-474

2012

Volltextzugriff (PDF)

The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population

British journal of cancer, 2005-10, Vol.93 (8), p.890-895

2005

Volltextzugriff (PDF)

Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: results from two phase 1 studies

Cancer Immunology, Immunotherapy, 2022-12, Vol.71 (12), p.2985-2998

2022

Volltextzugriff (PDF)

An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib

Targeted oncology, 2016-06, Vol.11 (3), p.401-415

2016

Volltextzugriff (PDF)

DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma

Annals of oncology, 2014-05, Vol.25 (5), p.968-974

2014

Volltextzugriff (PDF)

A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours

British journal of cancer, 2011-03, Vol.104 (5), p.750-755

2011

Volltextzugriff (PDF)

Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma

Journal of clinical oncology, 2000-01, Vol.18 (1), p.158-166

2000

Volltextzugriff (PDF)

High-intensity focused ultrasound for the treatment of liver tumours

Ultrasonics, 2004-04, Vol.42 (1), p.931-935

2004

Volltextzugriff (PDF)

Circulating melanoma cells and survival in metastatic melanoma

International journal of oncology, 2011-03, Vol.38 (3), p.755-760

2011

Volltextzugriff (PDF)

Adjuvant Interferon in High-Risk Melanoma: The AIM HIGH Study—United Kingdom Coordinating Committee on Cancer Research Randomized Study of Adjuvant Low-Dose Extended-Duration Interferon Alfa-2a in High-Risk Resected Malignant Melanoma

Journal of clinical oncology, 2004-01, Vol.22 (1), p.53-61

2004

Volltextzugriff (PDF)

Toxic epidermal necrolysis in a patient receiving vemurafenib for treatment of metastatic malignant melanoma

British journal of dermatology (1951), 2014-04, Vol.170 (4), p.997-999

2014

Volltextzugriff (PDF)

Beyond the theory: From holobiont concept to microbiome engineering

Environmental microbiology, 2023-04, Vol.25 (4), p.832-835

2023

Volltextzugriff (PDF)

Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors

Annals of oncology, 2013-03, Vol.24 (3), p.784-791

2013

Volltextzugriff (PDF)

16S rRNA gene‐based meta‐analysis of the reptile gut microbiota reveals environmental effects, host influences and a limited core microbiota

Molecular ecology, 2023-11, Vol.32 (22), p.6044-6058

2023

Volltextzugriff (PDF)

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma

Scientific reports, 2018-05, Vol.8 (1), p.7265-9, Article 7265

2018

Volltextzugriff (PDF)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma

British journal of surgery, 2012-02, Vol.99 (2), p.239-245

2012

Volltextzugriff (PDF)

Societal preference values for advanced melanoma health states in the United Kingdom and Australia

British journal of cancer, 2009-08, Vol.101 (3), p.387-389

2009

Volltextzugriff (PDF)

Circulating tumor DNA predicts survival in patients with resected high-risk stage II/III melanoma

Annals of oncology, 2018-02, Vol.29 (2), p.490-496

2018

Volltextzugriff (PDF)

Randomized Phase II Study of Temozolomide Given Every 8 Hours or Daily With Either Interferon Alfa-2b or Thalidomide in Metastatic Malignant Melanoma

Journal of clinical oncology, 2003-07, Vol.21 (13), p.2551-2557

2003

Volltextzugriff (PDF)

Multiple sclerosis health-related quality of life utility values from the UK MS register

Multiple sclerosis journal - experimental, translational and clinical, 2023-04, Vol.9 (2), p.20552173231178441-20552173231178441

2023

Volltextzugriff (PDF)

Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study

British journal of dermatology (1951), 2014-01, Vol.170 (1), p.87-95

2014

Volltextzugriff (PDF)

COVID-19 in Multiple Sclerosis: Clinically reported outcomes from the UK Multiple Sclerosis Register

Multiple sclerosis and related disorders, 2021-11, Vol.56, p.103317-103317, Article 103317

2021

Volltextzugriff (PDF)

Evaluation of cell death mechanisms induced by the vascular disrupting agent OXi4503 during a phase I clinical trial

British journal of cancer, 2012-05, Vol.106 (11), p.1766-1771

2012

Volltextzugriff (PDF)

A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage

Annals of oncology, 2015-04, Vol.26 (4), p.624-644

2015

Volltextzugriff (PDF)

Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer

British journal of cancer, 2011-06, Vol.104 (12), p.1822-1827

2011

Volltextzugriff (PDF)

1 – 25 von 2.673

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.376)
Mit Volltextzugriff
(2.335)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

n.n

Thema

Science & Technology
(1.653)
Life Sciences & Biomedicine
(1.283)
Humans
(985)
Female
(624)
Male
(576)
Biological And Medical Sciences
(510)
Medical Sciences
(420)
Middle Aged
(385)
Adult
(371)
Physical Sciences
(295)
Aged
(293)
Animals
(283)
Oncology
(174)
Physics
(166)
Technology
(164)
Adolescent
(151)
Aged, 80 And Over
(124)
General & Internal Medicine
(118)
Pharmacology. Drug Treatments
(116)
Fundamental And Applied Biological Sciences. Psychology
(113)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.245)
EZB Electronic Journals Library
(1.141)
Ingenta
(1.116)
Journals@Ovid Ovid Full Text
(920)
Publisher website
(650)
Elsevier ScienceDirect Journals
(590)
IngentaConnect Journals
(421)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(403)
Wiley Online Library
(396)
Wiley Online Library Full Collection 2018
(248)
Springer Nature
(196)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(152)
Oxford journals
(151)
Nature Journals Online
(131)
Taylor & Francis
(120)
JSTOR
(115)
Taylor & Francis Journals
(112)
Oxford Journals 2020 Medicine
(88)
Psychology & Behavioral Sciences Collection
(78)
APS: American Physical Society E-Journals (Physics)
(72)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)